MIRTAZAPINE TEVA 15 mg, comprimé pelliculé — plaquette(s) PVC PVDC aluminium de 30 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400936946583
  • CIP7 3694658
  • CIS 68022786

What the source publishes

Holder
TEVA SANTE
Active ingredients
MIRTAZAPINE
Form
comprimé pelliculé
Package
plaquette(s) PVC PVDC aluminium de 30 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
liste I
Marketing status
Déclaration d'arrêt de commercialisation
Authorised on
2005-08-08
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400936946583
{
  "cis": "68022786",
  "cip7": "3694658",
  "form": "comprimé pelliculé",
  "name": "MIRTAZAPINE TEVA 15 mg, comprimé pelliculé — plaquette(s) PVC PVDC aluminium de 30 comprimé(s)",
  "cip13": "3400936946583",
  "holder": "TEVA SANTE",
  "routes": [
    "orale"
  ],
  "holders": [
    "TEVA SANTE"
  ],
  "currency": "EUR",
  "marketed": false,
  "bdmStatus": "Warning disponibilité",
  "useDomain": "unknown",
  "publicPrice": "3.90",
  "authorisedOn": "2005-08-08",
  "compositions": [
    {
      "name": "MIRTAZAPINE",
      "nature": "SA",
      "strength": "15 mg",
      "linkageNumber": "1",
      "substanceCode": "45485",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "2.88",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "MIRTAZAPINE TEVA 15 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration d'arrêt de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "plaquette(s) PVC PVDC aluminium de 30 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65%"
  ],
  "marketingDeclaredOn": "2025-03-28",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "MIRTAZAPINE"
  ],
  "authorisationProcedure": "Procédure de reconnaissance mutuelle",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400936946583"